In the picture above, from left to right:
Fabio Macchi, Head of Scientific & Clinical Portofolio Development, Helsinn Integrative Care;
Glenn Sabin, Founder of FON Therapeutics, Inc.;
Stefano Pastorelli, Head of Helsinn Integrative Care;
Karin Hehenberger, Founder and CEO of Lyfebulb.
Helsinn Integrative Care recently participated in the Lyfebulb Connect event “Cancer and Nutrition”, attended by a diverse audience of investors, entrepreneurs, healthcare professionals and cancer patient organizations and bloggers.
Lyfebulb is a patient-centric organization which seeks to offer support for people affected by chronic disease through a broad support network. The aim of this meeting was to highlight the importance of a healthy diet and lifestyle as part of an approach to cancer treatment, both as a preventative strategy and for people living with and in recovery from the disease. For Helsinn Integrative Care, Helsinn’s newly launched food supplements division, this was a valuable opportunity to showcase the critical role that it can play in supporting people with cancer in making the right nutrition choices.
During the meeting Stefano Pastorelli, head of Helsinn Integrative Care, gave a presentation on the importance of identifying high quality food supplements, backed up with rigorous clinical evidence, to support people with cancer in making appropriate nutrition choices.
Speakers at the event included:
Karin Hehenberger, MD, PhD, CEO and founder of Lyfebulb
Robert Thomas, MD, Consultant Oncologist and Senior Clinical Tutor, Cambridge University
Stefano Pastorelli, head of Helsinn Integrative Care
Susan Bratton, Founder and CEO of Savior Health
Read more on "Lyfebulb connect: cancer and nutrition".
In the picture above:
Robert Thomas, MD, Consultant Oncologist and Senior Clinical Tutor,